Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, December 29, 2020
Immutep has prioritized the recommencement of the process of scaling up the manufacturing of its lead product candidate eftilagimod alpha.
read more
Wednesday, December 30, 2020
Aurinia Pharmaceuticals and Lonza have expanded their exclusive manufacturing relationship.
read more
Wednesday, December 30, 2020
Lipidor announced the Company has signed a new cooperation agreement with Aurena Laboratories AB.
read more
Wednesday, December 30, 2020
Relaxera Pharmazeutische Gesellschaft mbH & Co. KG and CBL Patras announce the signing of an exclusive contract for human relaxin-2.
read more
Wednesday, December 30, 2020
SAI is voluntarily recalling Paroex Chlorhexidine Gluconate Oral Rinse USP, 0.12% products bearing an expiration date from 12/31/2020 – 9/30/2022 to the consumer level.
read more
Thermo Fisher Scientific has announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif.
read more
GT Biopharma and CDMO Cytovance have reached an agreement for license rights to use certain bacterial and mammalian cell lines and for GMP manufacturing services performed to date regarding the Company's TriKE™ product candidates.
read more
Amgen announced the FDA has approved RIABNI, a biosimilar to Rituxan.
read more
Wednesday, January 06, 2021
Oncorus has signed a 15-year lease to build an 88,000 square foot GMP viral immunotherapy clinical manufacturing facility in Andover, Massachusetts.
read more
Akston Biosciences and LakePharma have established a strategic partnership.
read more
Tuesday, January 12, 2021
Alcami announced an additional $2 million investment to expand its oral solid development and manufacturing capabilities in Wilmington, NC.
read more
Wednesday, January 13, 2021
Catalent has entered into a definitive agreement to acquire the manufacturing and packaging operations of Acorda Therapeutics.
read more
Wednesday, January 13, 2021
RheinCell Therapeutics GmbH has received GMP certification and Manufacturing Authorization.
read more
Baxter BioPharma Solutions has entered into an agreement to provide sterile manufacturing services for NVX-CoV2373, Novavax’ COVID-19 recombinant nanoparticle vaccine candidate.
read more
Wednesday, January 20, 2021
Recipharm and Enzymatica have signed a broadened contract for the manufacture of ColdZyme.
read more